Buy today and pay later: Afterpay and zippay available at checkout.

0

Your Cart is Empty

Proactive Cancer Risk Test

Understand your genetic risk of developing certain cancers so you can make important health choices that are right for you.

The test looks for inherited gene variations that increase your risk of developing some of the most common types of cancer – including breast, bowel, skin and prostate cancer.

Some of the genes included on the test are: BRCA1, BRCA2, MLH1, MHS2, MSH6, PMS2, CHEK2 & ATM.


eugenecare+

Compliment your genetic journey and enjoy peace of mind with ongoing genetic support from our clinical team.

From $12.99 per month

Frequently asked questions

You can find the full list of conditions screened for here.

The results of Eugene’s proactive cancer risk test can help you learn if you have an increased chance of developing different cancers in your lifetime. The test screens for 65 genes known to be associated with different types of cancers, including breast, ovarian, bowel, kidney, prostate, stomach, pancreatic and brain cancer.


Approximately 5% of people who choose to have proactive cancer risk testing find that they carry a variation in one of these 65 genes, which may increase their lifetime risk of developing cancer. These results may inform management options that can reduce the chance of cancer developing. Depending on your results and the specific type of cancer risk identified, your genetic counsellor can explore possible options, including:

  • Screening to detect cancer at an early and treatable stage. This may take place in the form of more frequent screening depending on the type of cancer risk, such as regular mammograms for breast cancer risk, ultrasounds for kidney cancer risk, or colonoscopy for bowel cancer risk.
  • Medication to prevent or reduce the chance of developing cancer.
  • Surgery to prevent or reduce the chance of developing cancer. For example, a female with a genetic variation in the BRCA1 gene has approximately 80% risk of developing breast cancer by the time she is 80 years old. If she has a double mastectomy (removal of both breasts), her breast cancer risk reduces to less than 5%.


Your genetic counsellor will discuss your results with you and explore what, if any, screening or management options are available. Eugene’s genetic counsellors can refer you to specialist tertiary clinical services who can work together to create a customised cancer-risk management plan based on your needs and specific results.


It is important to understand that Eugene’s proactive cancer risk test cannot diagnose you with cancer or guarantee your cancer risk. This test cannot exclude all risk factors or causes of cancer. A negative (where no changes are found) test result does not rule out the risk of developing cancer. 


Suppose you have a strong family history of cancer or health or lifestyle risks that may impact your cancer risk. In that case, your genetic counsellor may recommend a referral to a tertiary clinical service for review.

Eugene’s proactive cancer risk test looks for inherited gene variations that increase someone’s risk of developing some of the most common types of cancer – including breast, ovarian, bowel and prostate cancer.

This test can help you better understand their genetic risk of developing certain cancers and create a personalised risk report and action plan.

This test is not targeted toward adults who are undergoing management for an active cancer diagnosis, for children, to diagnose cancer, or to confirm the presence/absence of a familial gene variant.

If you have a personal or family history that suggests you’d benefit from seeing a doctor or cancer specialist, we’ll reach out and let you know prior to testing your sample.